Agree trials are long and expensive and company already spent millions and many years in single arm study and now talk of new study is scary even though product may perform well in long run... IMO.
I won't be surprised if Stock price continues to slide but I expected that two board member who were sitting on board for last few years should resign and take responsibility of TGA failure as sacking of previous CEO is not good enough... IMO.
i don't support withdrawal from TGA but if CEO fails to create valuable sale in EU then we will be in difficult time..IMO.
Ann: OncoSil TGA regulatory update, page-38
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $85.35K | 9.403M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1278254 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 11789637 | 16 |
View Market Depth
| Last trade - 15.17pm 26/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |